TheCRE.com
CRE Homepage About The CRE Advisory Board Newsletter Search Links Representation Comments
Reg Week Archives
Data Access
Data Quality
Regulation by Litigation
Regulation by Information
Regulation by Appropriation
Special Projects
CRE Watch List
Emerging Regulatory Issues
Litigation
OMB Papers
Abstracts and Reviews
Guest Column
Voluntary Standards Program
CRE Report Card
Public Docket Preparation
Interactive Public Docket
Electronic Regulatory Reform
Consumer Response Service
Interactive Public Docket
Docket Service
Newsletter

Enter your email address and click "Sign-Up" to join CRE's electronic newsletter.

Consumer Response Service
CRE's innovative new service provides consumers with a constructive method of provoking positive change in corporate practices.

Go to CRS

Docket Service
Featured Items on TheCRE.com

The Nixon Forum

®:
CRE's Regulatory Action
of the Week


ATSDR Announces Development of New and Updated Toxicological Profiles

On May 12, 2008, the U. S. Agency for Toxic Substances and Disease Registry announced in the Federal Register that it was developing one new and five updated toxicological profiles. These Tox Profiles are being developed under the Superfund Amendments and Reauthorization Act of 1986 (42 U.S.C. 9601 et seq.), which amended the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (42 U.S.C. 9601 et seq.). These statutes require that ATSDR identify the substances that pose the greatest risk to human health at Superfund sites, and to develop profiles of the substances toxicity.

The five profiles currently under development are

1.Chromium.........................................  007440-47-3
2.Radon..............................................  010043-92-2
3.Cadmium..........................................  007440-43-9
4.Formaldehyde.................................... 000050-00-0
5.Manganese........................................ 007439-96-5
6.Perfluoroalkyls \*\............................... 000375-22-4
                                                            000335-67-1
                                                            001763-23-1
*Denotes new profile.

ATSDR explains in its Federal Register notice that Notice of the availability of drafts of these five updated and one new toxicological profiles for public review and comment will be published in the Federal Register on or about October 17, 2008, with notice of a 90-day public comment period for each profile. Following the close of the comment period, chemical-specific comments will be addressed, and, where appropriate, changes will be incorporated into each profile.

Additional information on these profiles is available at the ATSDR Web site: http://www.atsdr.cdc.gov/toxpro2.html.

  • Click here to read EPA Federal Register notice seeking comment on new and updated Tox Profiles

  • Information Collection Request of the Week

  • The Department of Commerce Surveys Expenses From U.S and Foreign Travelers
    The Department of Commerce is seeking information collection to survey and collect data on travel expenditures by method of payment (cash, credit card, etc.) from U.S. travelers returning from abroad and foreign travelers leaving the United States.
  • ICR of the Week
  • ICR Archive

  • Recent Regulatory Developments

  • Senate Rejects Media Ownership Rule
    The Senate has voted against the FCC's media ownership rule. The FCC rule allowed media companies to own both a newspaper and a TV station at the same time.
  • FCC To Attempt Emergency Network Again
    The FCC will attempt to develop a nationwide emergency communications network again.
  • Government To Issue New Lawsuit Rules
    The Bush Administration will modify rules regarding consumer lawsuits against manufacturers for faulty products.
  • Regulators To Investigate JP Morgan
    Federal regulators have announced that they may launch an investigation into JP Morgan Chase's recent activities.
  • Additional News (updated daily)


  • Updated Tuesday, Friday, Sunday

    Science Forum

  • FDA Issues Another Warning About Defective Heparin Drug
    Some medical facilities still have recalled heparin in their inventories, prompting the Food & Drug Administration (FDA) to issue yet another warning about the defective drug.
  • Additional News (updated daily)
    Updated Tuesday, Friday, Sunday
  • CBO POLICY STATEMENTS
    CBO Predicts 16 Percent Drop in Re-enlistments Upon Better GI Bill
    A new congressional report supports the Pentagon’s claims that vastly improved GI Bill benefits would hurt retention.

    The Congressional Budget Office, the nonpartisan analytical arm of Congress, said in a report Thursday that enactment of S 22, a bill promising to pay full tuition plus a stipend for veterans attending college, could lead to a 16 percent drop in re-enlistments.

    Overall, CBO’s cost estimate is slightly lower than the estimated price tag issued by the Bush administration. Congressional budget analysts predict S 22 would have an overall cost of $680 million in the first full year and $51.8 billion over 10 years.

  • Click to learn more.
  • Additional News


  • disclaimer
    Copyright Notice The Center for Regulatory Effectiveness [Copyright © 2007]. All right reserved.